These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6414646)

  • 1. Dopamine receptors in the denervated striatum: further supersensitivity by chronic haloperidol treatment.
    Reches A; Wagner RH; Jackson V; Yablonskaya-Alter E; Fahn S
    Brain Res; 1983 Sep; 275(1):183-5. PubMed ID: 6414646
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of neurotensin-dopamine receptor interactions in striatal membranes of the male rat. The influence of 6-hydroxydopamine-induced dopamine receptor supersensitivity.
    Fuxe K; Agnati LF; Martire M; Neumeyer A; Benfenati F; Frey P
    Acta Physiol Scand; 1986 Jan; 126(1):147-9. PubMed ID: 3006432
    [No Abstract]   [Full Text] [Related]  

  • 4. Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment.
    Coirini H; Schumacher M; Angulo JA; McEwen BS
    Eur J Pharmacol; 1990 Sep; 186(2-3):369-71. PubMed ID: 2127022
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term effects of nigro-striatal denervation of striatal [3H]haloperidol binding.
    Feuerstein C; Demenge P; Barrette G; Silice C; Guerin B; Mouchet P
    Eur J Pharmacol; 1981 Dec; 76(4):457-60. PubMed ID: 6799306
    [No Abstract]   [Full Text] [Related]  

  • 6. D-1 receptor supersensitivity in the rat striatum after unilateral 6-hydroxydopamine lesions.
    Buonamici M; Caccia C; Carpentieri M; Pegrassi L; Rossi AC; Di Chiara G
    Eur J Pharmacol; 1986 Jul; 126(3):347-8. PubMed ID: 3093251
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of supersensitivity of pre- and postsynaptic dopamine receptors on the activity of endogenous inhibitor of cAMP dependent protein kinase in rat striatum.
    Szmigielski A; Szadowska A; Szmigielska H
    Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):214-24. PubMed ID: 6098230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of haloperidol administration on in vivo extracellular dopamine in striatum and prefrontal cortex after partial dopamine lesions.
    Bean AJ; Roth RH
    Brain Res; 1991 May; 549(1):155-8. PubMed ID: 1909923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D2 receptors in the striatum and frontal cortex following chronic administration of haloperidol.
    Liskowsky DR; Potter LT
    Neuropharmacology; 1987 May; 26(5):481-3. PubMed ID: 2955242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal ganglia dopamine depletion does not alter D1 dopamine receptor binding properties.
    Trugman JM; Pronsky CJ; Wooten GF
    Adv Neurol; 1990; 53():107-10. PubMed ID: 2146858
    [No Abstract]   [Full Text] [Related]  

  • 11. Alterations in dopamine receptors: effect of lesion and haloperidol treatment.
    Goldstein M; Lew JY; Asano T; Ueta K
    Commun Psychopharmacol; 1980; 4(1):21-5. PubMed ID: 6105037
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum.
    Enz A; Goldstein M; Meller E
    Mol Pharmacol; 1990 Apr; 37(4):560-5. PubMed ID: 1970116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T; Knott P; Kaufmann H; Yahr M
    Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic modification of dopaminergic transmission and its effects on binding characteristics of dopamine transporter ligand 3H-GBR 12783 in the striatum.
    Valchár M; Bonnet JJ; Costentin J
    Act Nerv Super (Praha); 1989 Dec; 31(4):273-4. PubMed ID: 2561622
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors.
    Di Paolo T; Poyet P; Labrie F
    Eur J Pharmacol; 1981 Jul; 73(1):105-6. PubMed ID: 7198580
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of haloperidol and 6-hydroxydopamine on oral drug taking behavior in rats.
    Fuchs V; Burbes E; Coper H
    Drug Alcohol Depend; 1982; 10(2-3):191-8. PubMed ID: 6131801
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophysectomy does not alter the increase in striatal dopamine receptor density produced by 6-hydroxydopamine lesions in male rats.
    Hruska RE
    Neurosci Lett; 1986 Jul; 68(2):207-10. PubMed ID: 3092152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.